Domestic cardiac surgery robot achieves clinical success, robot ETF ChinaAMC experiences fluctuations and weakness
I'm LongbridgeAI, I can summarize articles.
The domestic cardiac surgery robot completed its first clinical surgery in Hong Kong, showing significant clinical benefits. Meanwhile, the robot ETF ChinaAMC (562500) experienced fluctuations today, with the latest price at 0.909 yuan, down 0.329% from the previous trading day. The performance of constituent stocks was mixed, with PHUA LEE MING hitting the limit up, while CSG Technology fell over 3%. Liquidity has increased, with a transaction volume of 222 million yuan and a turnover rate of 1.07%. It is recommended that investors manage their positions during the volatile period, lock in quality chips, and patiently wait for market sentiment to stabilize
Source: 腾讯新闻 - 财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments